JPMorgan Chase & Co. (NYSE:JPM) is among the defendants that are ready to go before United States District Judge Edward Harrington in Boston for what they say are legitimate private-equity practices against investor allegations that buyout firms and their bankers colluded to rig offers on takeovers, according to Bloomberg. Other defendants in the case include Goldman Sachs (NYSE:GS), The Blackstone Group (NYSE:BX), Carlyle Group (NYSE:CG), KKR (NYSE:KKR), Apollo Global Management (NASDAQ:APO), and Bain Capital.
Merck & Co. (NYSE:MRK) and GE Healthcare have reached a clinical study collaboration, license and supply agreement for the use of Flutemetamol, an investigational positron emission tomography imaging agent, in support of Merck’s development of MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme inhibitor and Merck’s lead investigational candidate for Alzheimer’s disease. GE Healthcare is a General Electric Company (NYSE:GE) division.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Microsoft Corporation (NASDAQ:MSFT) and Google’s (NASDAQ:GOOG) Motorola phone business are millions of dollars apart in their valuations of video and Wi-Fi patents in a crucial case before a federal judge in Seattle, says Reuters. A ruling is expected early in 2013 and the outcome could be key in the balance of power between the firms in the struggle over ownership of the tech that underlies popular smartphones, tablets and game consoles.
Verizon Communications (NYSE:VZ) and Nokia Corporation (NYSE:NOK) have restarted their relationship, says Chief Executive Stephen Elop of the latter, commenting that the two are “planning a lot of exciting things,” according to The Verge.
Investing Insights: Is Time Warner Cable’s Stock a Buy Now?